Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06516341Recruiting

Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation

Role: collaborator

NCT06833021Not Yet Recruiting

Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC)

Role: collaborator

NCT04549831Recruiting

Genetic Bases of COVID-19 Clinical Variability

Role: collaborator

All 3 trials loaded